COCRYSTAL PHARMA, INC. Proceeds from (Repayments of) Related Party Debt
COCRYSTAL PHARMA, INC. (COCP) reported Proceeds from (Repayments of) Related Party Debt of -$3.21 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-04-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2012-04-16
- COCRYSTAL PHARMA, INC. proceeds from (repayments of) related party debt for the quarter ending 2011-12-31 was $0.00.
- COCRYSTAL PHARMA, INC. proceeds from (repayments of) related party debt for the quarter ending 2011-09-30 was -$469.00, a 105.10% decline year-over-year.
- COCRYSTAL PHARMA, INC. proceeds from (repayments of) related party debt for the quarter ending 2010-12-31 was -$1.32K.
- COCRYSTAL PHARMA, INC. proceeds from (repayments of) related party debt for the quarter ending 2010-09-30 was $9.20K.
- COCRYSTAL PHARMA, INC. proceeds from (repayments of) related party debt for fiscal 2011 was -$3.21K, a 100.86% decline from fiscal 2010.
- COCRYSTAL PHARMA, INC. proceeds from (repayments of) related party debt for fiscal 2010 was $375.32K.
| Period end | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 6 month | Proceeds from (Repayments of) Related Party Debt 9 month | Proceeds from (Repayments of) Related Party Debt 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | -$469.00 derived: sum of 2 quarters · filed 2012-04-16 | -$3.21K 10-K · filed 2012-04-16 | |
| 2011-09-30 | -$469.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | -$3.21K 10-Q · filed 2011-11-21 | ||
| 2011-06-30 | -$2.74K 10-Q/A · filed 2011-09-09 | |||
| 2010-12-31 | -$1.32K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $7.88K derived: sum of 2 quarters · filed 2012-04-16 | $375.32K 10-K · filed 2012-04-16 | |
| 2010-09-30 | $9.20K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $376.64K 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $367.44K 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |